Saravanan S. Karuppagounder

Saravanan S. Karuppagounder

Cornell University

H-index: 32

North America-United States

About Saravanan S. Karuppagounder

Saravanan S. Karuppagounder, With an exceptional h-index of 32 and a recent h-index of 20 (since 2020), a distinguished researcher at Cornell University, specializes in the field of Pharmacology and Neuroscience.

His recent articles reflect a diverse array of research interests and contributions to the field:

Use of N-acetylcysteine to treat central nervous system disorders

Use of n-acetylcysteine to treat cns disorders

Methods of treatment comprising Selenoprotein P fragment-containing compounds

2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer’s resilience

Temporary induction of hypoxic adaptations by preconditioning fails to enhance Schwann cell transplant survival after spinal cord injury

A STING agonist preconditions against ischaemic stroke via an adaptive antiviral Type 1 interferon response

Hemin-induced death models hemorrhagic stroke and is a variant of classical neuronal ferroptosis

New mechanistic insights, novel treatment paradigms, and clinical progress in cerebrovascular diseases

Saravanan S. Karuppagounder Information

University

Position

Burke Neurological Institute, Weill Cornell Medicine

Citations(all)

5159

Citations(since 2020)

2918

Cited By

3259

hIndex(all)

32

hIndex(since 2020)

20

i10Index(all)

52

i10Index(since 2020)

36

Email

University Profile Page

Google Scholar

Saravanan S. Karuppagounder Skills & Research Interests

Pharmacology and Neuroscience

Top articles of Saravanan S. Karuppagounder

Use of N-acetylcysteine to treat central nervous system disorders

2023/12/28

Use of n-acetylcysteine to treat cns disorders

2018/12/6

Methods of treatment comprising Selenoprotein P fragment-containing compounds

2024/1/23

2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer’s resilience

Neuron

2023/9/20

Temporary induction of hypoxic adaptations by preconditioning fails to enhance Schwann cell transplant survival after spinal cord injury

Glia

2023/3

A STING agonist preconditions against ischaemic stroke via an adaptive antiviral Type 1 interferon response

Brain Communications

2022/6/1

Hemin-induced death models hemorrhagic stroke and is a variant of classical neuronal ferroptosis

Journal of Neuroscience

2022/3/9

Epigenetic regulators of neuronal ferroptosis identify novel therapeutics for neurological diseases: HDACs, transglutaminases, and HIF prolyl hydroxylases

2021/1/1

HIF1α stabilization in hypoxia is not oxidant-initiated

Elife

2021/10/1

Selenium-based therapies

2021/8/3

Hypoxia-inducible factor prolyl hydroxylase domain (PHD) inhibition after contusive spinal cord injury does not improve locomotor recovery

Plos one

2021/4/5

Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhage

Science immunology

2021/2/19

Prolylhydroxylase/atf4 inhibitors and methods of use for treating neural cell injury or death and conditions resulting therefrom

2020/11/19

Oxidants are dispensable for HIF1α stability in hypoxia

bioRxiv

2020/5/6

The drug adaptaquin blocks ATF4/CHOP-dependent pro-death Trib3 induction and protects in cellular and mouse models of Parkinson's disease

Neurobiology of disease

2020/3/1

HIF1α stability in hypoxia is not oxidant-initiated but can be tuned by redox regulation of the proteasome

bioRxiv

2020

Agro-industrial waste valorization to energy and value added products for environmental sustainability

Biomass valorization to bioenergy

2020

See List of Professors in Saravanan S. Karuppagounder University(Cornell University)

Co-Authors

academic-engine